{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:15:14Z","timestamp":1783509314553,"version":"3.55.0"},"reference-count":42,"publisher":"MDPI AG","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:p>Charcot neuroarthropathy is a devastating condition that places patients at risk for poor outcomes. Although the condition was first described in 1703, knowledge of the causative agent(s) has yet to be fully understood. Recent advances in genetic research have helped to identify potential mechanisms and pathways for the enigmatic destruction and deformities that are often associated with the condition; however, alternative pathways have been proposed. For the purpose of this discussion, we will discuss the human leukocyte antigen, which is one of the most researched contributors to autoimmune pathology and, more recently, has been linked to diabetic complications.<\/jats:p>","DOI":"10.7547\/21-176","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T13:35:15Z","timestamp":1694525715000},"source":"Crossref","is-referenced-by-count":0,"title":["Evidence of Autoimmune Involvement in the Pathogenesis of Charcot Neuroarthropathy: A Novel Hypothesis with Preliminary Data"],"prefix":"10.3390","volume":"113","author":[{"given":"Craig J.","family":"Verdin","sequence":"first","affiliation":[{"name":"Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgeanne G.","family":"Botek","sequence":"additional","affiliation":[{"name":"Cleveland Clinic, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy M.","family":"Owings","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Cleveland Clinic, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D","family":"Kingsley","sequence":"additional","affiliation":[{"name":"Kent State University, Kent, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","reference":[{"key":"B1","series-title":"Foot Ankle Spec","first-page":"97","article-title":"Prevalence of diabetic neuropathy in patients undergoing foot and ankle surgery","volume":"5","author":"Suder NC","year":"2012","unstructured":"Suder NC, Wukich DK: Prevalence of diabetic neuropathy in patients undergoing foot and ankle surgery. Foot Ankle Spec 5: 97, 2012."},{"key":"B2","series-title":"Diabetes Care","first-page":"98","article-title":"Lower-extremity amputation risk after Charcot arthropathy and diabetic foot ulcer","volume":"33","author":"Sohn MW","year":"2010","unstructured":"Sohn MW, Stuck RM, Pinzur M, : Lower-extremity amputation risk after Charcot arthropathy and diabetic foot ulcer. Diabetes Care 33: 98, 2010."},{"key":"B3","series-title":"Diabetes Care","first-page":"1694","article-title":"Association between osteoprotegerin G1181C and T245G polymorphisms and diabetic Charcot neuroarthropathy: a case-control study","volume":"32","author":"Pitocco D","year":"2009","unstructured":"Pitocco D, Zrlano G, Gioffre G, : Association between osteoprotegerin G1181C and T245G polymorphisms and diabetic Charcot neuroarthropathy: a case-control study. Diabetes Care 32: 1694, 2009."},{"key":"B4","series-title":"Diabetes Med","first-page":"771","article-title":"Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy","volume":"29","author":"Korzon-Burakowska A","year":"2012","unstructured":"Korzon-Burakowska A, Jakobkiewwicz-Banecka J, Fiedosiuk A, : Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy. Diabetes Med 29: 771, 2012."},{"key":"B5","series-title":"Sci Rep","first-page":"501","article-title":"Prevalence of polymorphisms in OPG, RANKL and RANK as potential markers for Charcot arthropathy development","volume":"7","author":"Bruhn-Olszewska B","year":"2017","unstructured":"Bruhn-Olszewska B, Korzon-Burakowska A, W\u0119grzyn G, : Prevalence of polymorphisms in OPG, RANKL and RANK as potential markers for Charcot arthropathy development. Sci Rep 7: 501, 2017."},{"key":"B6","series-title":"J Diabetes Metab Disord","first-page":"287","article-title":"Selected RANKL\/RANK\/OPG system genetic variants in diabetic foot patients","volume":"17","author":"Mrozikiewicz-Rakowska B","year":"2018","unstructured":"Mrozikiewicz-Rakowska B, Nehring P, Szyma\u0144ski K: Selected RANKL\/RANK\/OPG system genetic variants in diabetic foot patients. J Diabetes Metab Disord 17: 287, 2018."},{"key":"B7","series-title":"Int J Low Extrem Wounds","first-page":"287","article-title":"RANKL gene polymorphism as a potential biomarker to identify acute Charcot foot among Indian population with type 2 diabetes: a preliminary report","volume":"18","author":"SaiPrathiba A","year":"2019","unstructured":"SaiPrathiba A, Senthil G, Juttada U, : RANKL gene polymorphism as a potential biomarker to identify acute Charcot foot among Indian population with type 2 diabetes: a preliminary report. Int J Low Extrem Wounds 18: 287, 2019."},{"key":"B8","series-title":"Diabetologia","first-page":"1035","article-title":"Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand","volume":"51","author":"Mabilleau G","year":"2008","unstructured":"Mabilleau G, Petrova NL, Edmonds ME, : Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand. Diabetologia 51: 1035, 2008."},{"key":"B9","series-title":"Autoimmunity: From Bench to Bedside","article-title":"\u201cMajor Histocompatibility Complex: Antigen Processing and Presentation,\u201d","author":"Cruz-Tapias P","year":"2013","unstructured":"Cruz-Tapias P, Castiblanco J, Anaya JM: \u201cMajor Histocompatibility Complex: Antigen Processing and Presentation,\u201d in Autoimmunity: From Bench to Bedside [Internet], edited by Anaya JM, Shoenfeld Y, Rojas-Villarraga A, , El Rosario University Press, Bogota, Colombia, 2013."},{"key":"B10","series-title":"Neural Regen Res","first-page":"1839","article-title":"HLA class II alleles and risk for peripheral neuropathy in type 2 diabetes patients","volume":"11","author":"Marzban A","year":"2016","unstructured":"Marzban A, Kiani J, Hajilooi M, : HLA class II alleles and risk for peripheral neuropathy in type 2 diabetes patients. Neural Regen Res 11: 1839, 2016."},{"key":"B11","series-title":"J Diabetes Res","first-page":"5910639","article-title":"Corneal subbasal nerve plexus changes in severe diabetic Charcot foot deformity: a pilot study in search for a DNOAP biomarker","volume":"2018","author":"Herlyn A","year":"2018","unstructured":"Herlyn A, Prakasam RK, Peschel S, : Corneal subbasal nerve plexus changes in severe diabetic Charcot foot deformity: a pilot study in search for a DNOAP biomarker. J Diabetes Res 2018: 5910639, 2018."},{"key":"B12","series-title":"Eur J Ophthalmol","first-page":"89","article-title":"Diabetic retinopathy and HLA antigens in type 2 diabetes mellitus","volume":"12","author":"Birinci A","year":"2002","unstructured":"Birinci A, Birinci H, Abidinoglu R, : Diabetic retinopathy and HLA antigens in type 2 diabetes mellitus. Eur J Ophthalmol 12: 89, 2002."},{"key":"B13","series-title":"Eur J Ophthalmol","first-page":"638","article-title":"HLA-DQB1 subtypes predict diabetic retinopathy in patients with type I diabetes mellitus","volume":"19","author":"Khazaee MH","year":"2009","unstructured":"Khazaee MH, Afshari JT, Khazaee B, : HLA-DQB1 subtypes predict diabetic retinopathy in patients with type I diabetes mellitus. Eur J Ophthalmol 19: 638, 2009."},{"key":"B14","series-title":"Hum Immunol","first-page":"1031","article-title":"Contribution of HLA class II genes to end stage renal disease in Mexican patients with type 2 diabetes mellitus","volume":"61","author":"P\u00e9rez-Luque E","year":"2000","unstructured":"P\u00e9rez-Luque E, Malacara JM, Olivo-D\u00edaz A, : Contribution of HLA class II genes to end stage renal disease in Mexican patients with type 2 diabetes mellitus. Hum Immunol 61: 1031, 2000."},{"key":"B15","series-title":"Endocr Metab Immune Disord Drug Targets","first-page":"1157","article-title":"Human leukocyte antigens (HLA) genes association in type 1 diabetic nephropathy","volume":"19","author":"Mihoubi E","year":"2019","unstructured":"Mihoubi E, Amroun H, Raache R, : Human leukocyte antigens (HLA) genes association in type 1 diabetic nephropathy. Endocr Metab Immune Disord Drug Targets 19: 1157, 2019."},{"key":"B16","series-title":"Singapore Med J","first-page":"198","article-title":"Risk factors of diabetic foot Charcot arthropathy: a case-control study at a Malaysian tertiary care centre","volume":"57","author":"Fauzi AA","year":"2016","unstructured":"Fauzi AA, Chung TY, Latif LA: Risk factors of diabetic foot Charcot arthropathy: a case-control study at a Malaysian tertiary care centre. Singapore Med J 57: 198, 2016."},{"key":"B17","series-title":"Diabetes Metab Res Rev","first-page":"2","article-title":"Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus","volume":"33","author":"Rizzo P","year":"2017","unstructured":"Rizzo P, Pitocco D, Zaccardi F, : Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus. Diabetes Metab Res Rev 33: 2, 2017."},{"key":"B18","series-title":"Am J Med","first-page":"9","article-title":"Rheumatoid arthritis: relationship with HLA-D","volume":"75","author":"Stastny P","year":"1983","unstructured":"Stastny P: Rheumatoid arthritis: relationship with HLA-D. Am J Med 75: 9, 1983."},{"key":"B19","series-title":"Ann Rheum Dis","first-page":"227","article-title":"HLA class II is associated with distal interphalangeal osteoarthritis","volume":"62","author":"Riyazi N","year":"2003","unstructured":"Riyazi N, Spee J, Huizinga TW, : HLA class II is associated with distal interphalangeal osteoarthritis. Ann Rheum Dis 62: 227, 2003."},{"key":"B20","series-title":"J Rheumatol","first-page":"1298","article-title":"HLA antigens and primary osteoarthritis of the hand","volume":"30","author":"Merlotti D","year":"2003","unstructured":"Merlotti D, Santacroce C, Gennari L, : HLA antigens and primary osteoarthritis of the hand. J Rheumatol 30: 1298, 2003."},{"key":"B21","series-title":"Curr Clin Microbiol Rep","first-page":"124","article-title":"Reactive arthritis: update","volume":"7","author":"Bentaleb I","year":"2020","unstructured":"Bentaleb I, Abdelghani KB, Rostom S, : Reactive arthritis: update. Curr Clin Microbiol Rep 7: 124, 2020."},{"key":"B22","series-title":"Ital J Anat Embryol","first-page":"342","article-title":"HLA-G molecules are constitutively expressed by human synovial fibroblasts and up-modulated in osteoarthritis","volume":"115","author":"De Mattei M","year":"2010","unstructured":"De Mattei M, Rizzo R, Stignani M, : HLA-G molecules are constitutively expressed by human synovial fibroblasts and up-modulated in osteoarthritis. Ital J Anat Embryol 115: 342, 2010."},{"key":"B23","series-title":"Foot Ankle Int","first-page":"1541","article-title":"Charcot arthropathy of the foot and ankle associated with rheumatoid arthritis","volume":"34","author":"Grear BJ","year":"2013","unstructured":"Grear BJ, Rabinovich A, Brodsky JW: Charcot arthropathy of the foot and ankle associated with rheumatoid arthritis. Foot Ankle Int 34: 1541, 2013."},{"key":"B24","series-title":"J Foot Ankle Surg","first-page":"1229","article-title":"Charcot reconstruction: outcomes in patients with and without diabetes","volume":"59","author":"Cates NK","year":"2020","unstructured":"Cates NK, Wagler EC, Bunka TJ, : Charcot reconstruction: outcomes in patients with and without diabetes. J Foot Ankle Surg 59: 1229, 2020."},{"key":"B25","series-title":"Ann Rheum Dis","first-page":"260","article-title":"FGF2 induces RANKL gene expression as well as IL1Beta regulated MHC class II in human bone marrow-derived mesenchymal progenitor stromal cells","volume":"74","author":"Bocelli-Tyndall C","year":"2015","unstructured":"Bocelli-Tyndall C, Trella E, Frachet A, : FGF2 induces RANKL gene expression as well as IL1Beta regulated MHC class II in human bone marrow-derived mesenchymal progenitor stromal cells. Ann Rheum Dis 74: 260, 2015."},{"key":"B26","series-title":"J Interferon Cytokine Res","first-page":"927","article-title":"A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis","volume":"31","author":"Astry B","year":"2011","unstructured":"Astry B, Harberts E, Moudgil KD: A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis. J Interferon Cytokine Res 31: 927, 2011."},{"key":"B27","series-title":"Transplantation","first-page":"642","article-title":"Charcot neuroarthropathy after simultaneous pancreas-kidney transplant","volume":"96","author":"Rangel \u00c9B","year":"2012","unstructured":"Rangel \u00c9B, S\u00e1 JR, Gomes SA, : Charcot neuroarthropathy after simultaneous pancreas-kidney transplant. Transplantation 96: 642, 2012."},{"key":"B28","series-title":"Clin Transplant","first-page":"712","article-title":"Charcot neuroarthropathy after simultaneous pancreas-kidney transplantation: risk factors, prevalence, and outcome","volume":"29","author":"Garc\u00eda Barrado F","year":"2015","unstructured":"Garc\u00eda Barrado F, Kuypers DR, Matricali GA: Charcot neuroarthropathy after simultaneous pancreas-kidney transplantation: risk factors, prevalence, and outcome. Clin Transplant 29: 712, 2015."},{"key":"B29","series-title":"J Foot Ankle Surg","first-page":"475","article-title":"Development of Charcot neuroarthropathy in diabetic patients who received kidney or kidney-pancreas transplants","volume":"58","author":"Anthony ML","year":"2019","unstructured":"Anthony ML, Cravey KS, Atway SA: Development of Charcot neuroarthropathy in diabetic patients who received kidney or kidney-pancreas transplants. J Foot Ankle Surg 58: 475, 2019."},{"key":"B30","series-title":"Tissue Antigens","first-page":"357","article-title":"Increased frequency of HLA\u2013DRw2 and DRw3 in multiple sclerosis","volume":"13","author":"de Moerloose P","year":"1979","unstructured":"de Moerloose P, Jeannet M, Martins-da-Silva B, : Increased frequency of HLA\u2013DRw2 and DRw3 in multiple sclerosis. Tissue Antigens 13: 357, 1979."},{"key":"B31","series-title":"J Am Acad Orthop Surg","first-page":"100","article-title":"Neuropathic arthropathy: review of current knowledge","volume":"4","author":"Alpert SW","year":"1996","unstructured":"Alpert SW, Koval KJ, Zuckerman JD: Neuropathic arthropathy: review of current knowledge. J Am Acad Orthop Surg 4: 100, 1996."},{"key":"B32","series-title":"Semin Vasc Surg","first-page":"66","article-title":"Diabetic foot ulcerations: biomechanics, charcot foot, and total contact cast","volume":"25","author":"Malhotra S","year":"2012","unstructured":"Malhotra S, Bello E, Kominsky S: Diabetic foot ulcerations: biomechanics, charcot foot, and total contact cast. Semin Vasc Surg 25: 66, 2012."},{"key":"B33","series-title":"J Orthop Trauma Rehabil","first-page":"52","article-title":"Multiple sclerosis neuropathic arthropathy of elbow: report of a rare case and literature review","volume":"26","author":"Hassani M","year":"2019","unstructured":"Hassani M, Shariyate MJ, Abbasi B, : Multiple sclerosis neuropathic arthropathy of elbow: report of a rare case and literature review. J Orthop Trauma Rehabil 26: 52, 2019."},{"key":"B34","series-title":"Endocrinology","first-page":"1008","article-title":"High glucose levels increase major histocompatibility complex class I gene expression in thyroid cells and amplify interferon-gamma action","volume":"143","author":"Napolitano G","year":"2002","unstructured":"Napolitano G, Bucci I, Giuliani C, : High glucose levels increase major histocompatibility complex class I gene expression in thyroid cells and amplify interferon-gamma action. Endocrinology 143: 1008, 2002."},{"key":"B35","series-title":"Ann Surg","first-page":"845","article-title":"Short-term hyperglycemia in surgical patients and a study of related cellular mechanisms","volume":"243","author":"Turina M","year":"2006","unstructured":"Turina M, Miller FN, Tucker CF, : Short-term hyperglycemia in surgical patients and a study of related cellular mechanisms. Ann Surg 243: 845, 2006."},{"key":"B36","series-title":"J Diabetes Res","first-page":"2180819","article-title":"Expression profile of genes potentially associated with adequate glycemic control in patients with type 2 diabetes mellitus","volume":"2017","author":"Corbi SCT","year":"2017","unstructured":"Corbi SCT, Bastos AS, Nepomuceno R, : Expression profile of genes potentially associated with adequate glycemic control in patients with type 2 diabetes mellitus. J Diabetes Res 2017: 2180819, 2017."},{"key":"B37","series-title":"Diabetologia","first-page":"1085","article-title":"Charcot neuroarthropathy in diabetes mellitus","volume":"45","author":"Rajbhandari SM","year":"2002","unstructured":"Rajbhandari SM, Jenkins RC, Davies C, : Charcot neuroarthropathy in diabetes mellitus. Diabetologia 45: 1085, 2002."},{"key":"B38","series-title":"J Wound Care","first-page":"57","article-title":"Surgically induced Charcot neuroarthropathy following partial forefoot amputation in diabetes","volume":"16","author":"Zgonis T","year":"2007","unstructured":"Zgonis T, Stapleton JJ, Shibuya N, : Surgically induced Charcot neuroarthropathy following partial forefoot amputation in diabetes. J Wound Care 16: 57, 2007."},{"key":"B39","series-title":"Diabet Med","first-page":"1380","article-title":"Unresolved issues in the management of ulcers of the foot in diabetes","volume":"25","author":"Jeffcoate WJ","year":"2008","unstructured":"Jeffcoate WJ, Lipsky BA, Berendt AR, : Unresolved issues in the management of ulcers of the foot in diabetes. Diabet Med 25: 1380, 2008."},{"key":"B40","series-title":"Diabet Med","first-page":"1469","article-title":"Charcot neuroarthropathy triggered by osteomyelitis and\/or surgery","volume":"25","author":"Ndip A","year":"2008","unstructured":"Ndip A, Jude EB, Whitehouse R, : Charcot neuroarthropathy triggered by osteomyelitis and\/or surgery. Diabet Med 25: 1469, 2008."},{"key":"B41","series-title":"Diabetes Care","first-page":"1617","article-title":"Loss of RAGE defense: a cause of Charcot neuroarthropathy?","volume":"34","author":"Witzke KA","year":"2011","unstructured":"Witzke KA, Vinik AI, Grant LM, : Loss of RAGE defense: a cause of Charcot neuroarthropathy? Diabetes Care 34: 1617, 2011."},{"key":"B42","series-title":"Diabetologia","first-page":"563","article-title":"HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus","volume":"56","author":"Strollo R","year":"2013","unstructured":"Strollo R, Rizzo P, Spoletini M, : HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus. Diabetologia 56: 563, 2013."}],"container-title":["Journal of the American Podiatric Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/japmaonline.org\/view\/journals\/apms\/113\/4\/21-176.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/japmaonline.org\/view\/journals\/apms\/113\/4\/21-176.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/japmaonline.org\/view\/journals\/apms\/113\/4\/21-176.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:19:19Z","timestamp":1783505959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1930-8264\/113\/4\/21176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":42,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.7547\/21-176","relation":{},"ISSN":["8750-7315"],"issn-type":[{"value":"8750-7315","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]}}}